Celldex Therapeutics shares owned by Redmile Group
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Redmile Group
from 13F filings
Historical chart of Redmile Group investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Redmile Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Redmile Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $39M | 994k | 39.66 |
| 2023-09-30 | $45M | 1.6M | 27.52 |
| 2023-06-30 | $58M | 1.7M | 33.93 |
| 2023-03-31 | $68M | 1.9M | 35.98 |
| 2022-12-31 | $88M | 2.0M | 44.57 |
| 2022-09-30 | $56M | 2.0M | 28.11 |
| 2022-06-30 | $56M | 2.1M | 26.96 |
| 2022-03-31 | $70M | 2.0M | 34.06 |
| 2021-12-31 | $84M | 2.2M | 38.64 |
| 2021-09-30 | $164M | 3.0M | 53.99 |
| 2021-06-30 | $101M | 3.0M | 33.44 |
| 2021-03-31 | $70M | 3.4M | 20.60 |
| 2020-12-31 | $48M | 2.7M | 17.52 |
| 2020-09-30 | $30M | 2.0M | 14.83 |
| 2020-06-30 | $26M | 2.0M | 13.00 |